Dr. Sameer Thapar is Oracle Health Science Consulting’s Director of Global Pharmacovigilance and concurrently Professor, Drug safety and Pharmacovigilance, in a Masters level program at a NJ University. As a subject matter expert in pharmacovigilance operations and compliance, he has built global departments and defended in successful FDA, MHRA, and EMA health authority inspections. He is well versed in a multitude of therapeutic areas and PV-related databases. Dr. Thapar is published in industry journals and an invited speaker to global pharmaceutical conferences.